Search details
1.
Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients.
N Engl J Med
; 386(6): 509-520, 2022 02 10.
Article
in English
| MEDLINE | ID: mdl-34914868
2.
Molnupiravir for the treatment of COVID-19 in immunocompromised participants: efficacy, safety, and virology results from the phase 3 randomized, placebo-controlled MOVe-OUT trial.
Infection
; 51(5): 1273-1284, 2023 Oct.
Article
in English
| MEDLINE | ID: mdl-36648627
3.
Scientific and regulatory reasons for delay and denial of FDA approval of initial applications for new drugs, 2000-2012.
JAMA
; 311(4): 378-84, 2014.
Article
in English
| MEDLINE | ID: mdl-24449316
Results
1 -
3
de 3
1
Next >
>>